Join the club for FREE to access the whole archive and other member benefits.

Jason Holland

Principal Investigator at University of Zurich.

Jason is from Yorkshire in the United Kingdom and received a master’s degree in Chemistry from the University of York (MChem, 2004) followed by a doctorate from the University of Oxford (D.Phil, 2008). He trained as post-doctoral scholar with Jason S. Lewis in radiochemistry and translational molecular imaging at Memorial Sloan-Kettering Cancer Center in New York (2008 – 2010). He was then awarded an ETH Fellowship and worked at ETH Zürich and the Paul Scherrer Institute (2010 – 2012). Following this he was appointed as Assistant in Chemistry in the Division of Nuclear Medicine and Molecular Imaging at Massachusetts General Hospital, Boston, with a joint faculty appointment as an Instructor in Radiology at Harvard Medical School (2012 – 2014). In 2015, he worked in the Department of Nuclear Medicine at the University Hospital Freiburg as a Visiting Scientist. In April 2016, Jason began his research group as an SNSF Professor in the Department of Chemistry at the University of Zurich, funded by the European Research Council, the Swiss National Science Foundation and the University of Zurich. Research activities focus on advancing radiochemical methods with various radionuclides (18F, 64Cu, 68Ga, 90Y, 89Zr, 111In, 177Lu etc), and developing molecular imaging agents that target oncogenic signalling pathways in cancer.

Visit website: https://www.hollandlab.org/group

See also: Academia University of Zurich - Public Research university.

Details last updated 21-Nov-2019

Jason Holland News

Graphene nanoflakes can deliver drugs to target tissues

Graphene nanoflakes can deliver drugs to target tissues

Phys.org - 19-Aug-2019

Tested on mice model - need to slow down excretion from tissues